Every quarter the headlines say behavioral health M&A is slowing down. The deal count in the trade press is down, the mega-platform deals are fewer, and the takeaway everyone repeats is that the market has cooled.

That is not what the middle of the market looks like. Deals are still getting done — they just do not look like the clean, all-cash, single-buyer transactions that get written up. What has changed is the structure.

The structures replacing the clean cash exit

Over the past six months, the shape of the deals we are working has shifted noticeably:

  • MSAs with buyouts built in. A management services agreement that runs the operation today with a purchase option triggered on a future date. The buyer gets operating control now; the owner gets a path to a full exit later, without having to sell at today's number.
  • Seller financing at levels that did not exist three years ago. We recently brought a deal to market structured with 90% seller financing. A few years ago that would have been unthinkable. Today it is what gets a transaction across the line when buyer capital is expensive.
  • Joint ventures instead of outright sales. When a clean cash exit is not realistic, an owner can contribute the facility into a venture and keep an equity position — taking some liquidity now and participating in the upside later.

Why this is happening

Two things are true at once. Buyers are more disciplined about what they will pay and how much leverage they will take on. And owners with genuinely good operations are not interested in selling at a discount just because the headlines are soft.

Creative structuring is what resolves that standoff. Instead of arguing over a single purchase price, the parties negotiate over who carries what risk, for how long, and at what point the ownership actually transfers. That conversation is more work, and it requires an advisor who understands both the operating side and the capital side — but it closes deals that would otherwise die on price.

The market has split in two

What we see now is a real divergence between two kinds of operators:

  • Operators who can adapt to the current market are still transacting, and still on their own terms.
  • Operators who have not adapted are increasingly partnering through equity with newer, more flexible players just to stay in the game — giving up more of the upside than they would have a few years ago.

The difference is rarely the quality of the clinical program. It is usually whether the owner is willing to accept a structure other than "cash, at close, at my price."

What this means if you are thinking about a sale

If your operations do not support a clean cash exit right now — thin margins, payer concentration, a lease that will not survive a change of ownership, or a market where buyers have gotten picky — that does not mean you cannot transact. It means the structure matters more than the headline price.

Three questions worth answering before you go to market:

  • What is the minimum cash you need at close, and what can be deferred?
  • Are you willing to stay involved operationally for a defined period, and if so, for how long and at what cost?
  • Is an equity position in the combined business worth more to you than a smaller all-cash number today?

Owners who can answer those questions honestly, and who have an advisor who can structure around the answers, are the ones still getting deals done in this market.

If you are trying to exit but your operations do not allow for a clean cash exit — or you are looking for your next deal and want a creative structure on the table — that is the conversation we have every week. Sell-side advisory and buy-side representation are both open, and the first call is confidential.

If you operate detox or residential beds, our page on detox and residential transactions covers what buyers underwrite in that asset class. Recovery housing is a different business — see sober living and recovery housing for the per-bed and lease economics that drive those deals.